Trial NCT02621515

View at ClinicalTrials.gov 
Org. Study IDs: 201500776

Last trial update was posted on 2018-07-26

MeSH Interventions

Nivolumab

MeSH Conditions

Brain Neoplasms Melanoma Neoplasm Metastasis

Other Conditions

Brain Metastasis

Stopping Reasons

In the Netherlands we wanted to add pilimumab to nivolumab. This resulted in a very long METC procedure which resulted in a to slow inclusion rate.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID